Skip to main content
. Author manuscript; available in PMC: 2022 Apr 10.
Published in final edited form as: ACS Biomater Sci Eng. 2019 Dec 9;6(1):505–516. doi: 10.1021/acsbiomaterials.9b00861

Table 1.

Description and Rationale for the Scaffolds Used in the Study

Gel100 positive control material to compare to gelatin–PU materials
Gel80–PU20 candidate scaffold showing a significant improvement over Gel100 without long degradation periods, which are typical of polycarbonate PUs36
DRM an established commercial product that is being used clinically and is a collagen-based scaffold